Elevated urinary total sialic acid and increased oxidative stress in patients with bladder cancer

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.10.3322/CA.2007.0010Search in Google Scholar

2. McNeil BK, Getzenberg RH. Urine-based markers in bladder cancer: future prospects. BJU Int. 2008; 101: 668-9.10.1111/j.1464-410X.2007.07439.xSearch in Google Scholar

3. Sriplung S. Urinary bladder. In Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P eds,. Cancer in Thailand Vol IV 1998-2000 Bangkok: Bangkok Medical Publisher, 2007: p. 61-2.Search in Google Scholar

4. Sanchez-Carbayo M. Recent advances in bladder cancer diagnostics. Clin Biochem. 2004; 37:562-71.10.1016/j.clinbiochem.2004.05.014Search in Google Scholar

5. Miyagi T, Wada T, Yamaguchi K, Hata K. Sialidase and malignancy: a minireview. Glycoconj J. 2004; 20: 189-98.10.1023/B:GLYC.0000024250.48506.bfSearch in Google Scholar

6. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J. 2004; 20:353-64.10.1023/B:GLYC.0000033631.35357.41Search in Google Scholar

7. Crook M. The determination of plasma or serum sialic acid. Clin Biochem. 1993; 26:31-38.10.1016/0009-9120(93)90014-WSearch in Google Scholar

8. Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci. 1994; 24:376-84.Search in Google Scholar

9. Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest. 1999; 29:413-25.10.1046/j.1365-2362.1999.00485.xOpen DOISearch in Google Scholar

10. Patel PS, Baxi BR, Adhvaryu SG, Balar DB. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 1990; 10:1071-4.Search in Google Scholar

11. Feijoo C, Paez de la Cadena M, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Sialic acid levels in serum and tissue from colorectal cancer patients. Cancer Lett. 1997; 112:155-60.10.1016/S0304-3835(96)04564-8Search in Google Scholar

12. Wongkham S, Boonla C, Kongkham S, Wongkham C, Bhudhisawasdi V, Sripa B. Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clin Biochem. 2001; 34:537-41.10.1016/S0009-9120(01)00265-XOpen DOISearch in Google Scholar

13. Hobarth K, Hofbauer J, Fang-Kircher S. Plasma sialic acid in patients with prostate cancer. Br J Urol. 1993; 72:621-4.10.1111/j.1464-410X.1993.tb16221.x10071549Search in Google Scholar

14. Dunzendorfer U, Katopodis N, Dnistrian AM, Stock CC, Schwartz MK, Whitmore WF, Jr. Plasma lipid bound sialic acid in patients with prostate and bladder cancer. Invest Urol. 1981; 19:194-6.Search in Google Scholar

15. Oztokatli A, Ozkardes H, Ovul E, Erol D. The significance of serum lipid-bound sialic acid in bladder tumours. Int Urol Nephrol. 1992; 24:125-9.10.1007/BF02549639Open DOISearch in Google Scholar

16. Lagana A, Pardo-Martinez B, Marino A, Fago G, Bizzarri M. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker. Clin Chim Acta. 1995; 243: 165-79.10.1016/0009-8981(95)06165-7Search in Google Scholar

17. Akcay T, Konukoglu D, Erosenci A, Ataus S, Dirican A, Uygur C. Urinary excretion of sialic acid in patients with superficial bladder tumors. Cancer Lett. 1994; 78: 7-9.10.1016/0304-3835(94)90024-8Open DOISearch in Google Scholar

18. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004; 44:239-67.10.1146/annurev.pharmtox.44.101802.121851Open DOISearch in Google Scholar

19. Akcay T, Saygili I, Andican G, Yalcin V. Increased formation of 8-hydroxy-2'-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol Int. 2003; 71:271-4.10.1159/000072677Search in Google Scholar

20. Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta. 2003; 334:87-94.10.1016/S0009-8981(03)00191-8Search in Google Scholar

21. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol. 2010; 28:360-7.10.1016/j.urolonc.2008.12.010Open DOISearch in Google Scholar

22. Hoogwerf BJ, Laine DC, Greene E. Urine C-peptide and creatinine (Jaffe method) excretion in healthy young adults on varied diets: sustained effects of varied carbohydrate, protein, and meat content. Am J Clin Nutr. 1986; 43:350-60.10.1093/ajcn/43.3.350Open DOISearch in Google Scholar

23. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961; 81: 384-92.10.1042/bj0810384Open DOISearch in Google Scholar

24. Marshall PJ, Warso MA, Lands WE. Selective microdetermination of lipid hydroperoxides. Anal Biochem. 1985; 145:192-9.10.1016/0003-2697(85)90347-1Search in Google Scholar

25. Taylor JA, 3rd, Kuchel GA. Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction. Nat Clin Pract Urol. 2009; 6:135-44.10.1038/ncpuro1315295787219265855Open DOISearch in Google Scholar

26. Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009; 4:251-85.10.1146/annurev.pathol.4.110807.092230Search in Google Scholar

27. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res. 2009; 674:85-92.10.1016/j.mrgentox.2008.09.020Search in Google Scholar

28. Konety BR, Getzenberg RH. Urine based markers ofurological malignancy. J Urol. 2001; 165:600-11. 10.1097/00005392-200102000-00081Search in Google Scholar

29. Konukoglu D, Akcay T, Celik C, Erozenci A. Urinary excretion of sialic acid in patients with bladder tumors. Cancer Lett. 1995; 94:97-100.10.1016/0304-3835(95)03830-PSearch in Google Scholar

30. Basoglu M, Atamanalp SS, Yildirgan MI, Aydinli B, Ozturk G, Akcay F, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007; 39:136-40.10.1159/000100110Search in Google Scholar

31. Sebzda T, Saleh Y, Gburek J, Warwas M, Andrzejak R, Siewinski M, et al. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage. J Exp Ther Oncol. 2006; 5:223-9.Search in Google Scholar

32. Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, et al. Five tumor markers in lung cancer: significance of total and “lipid”-bound sialic acid. Anticancer Res. 1991; 11:2107-10.Search in Google Scholar

33. Reganon E, Vila V, Martinez-Sales V, Vaya A, Mira Y, Ferrando F, et al. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis. Thromb Res. 2007; 119:73-8.10.1016/j.thromres.2005.12.017Search in Google Scholar

34. Ekin S, Mert N, Gunduz H, Meral I. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2003; 94:193-201.10.1385/BTER:94:3:193Open DOISearch in Google Scholar

35. Goswami K, Nandeesha H, Koner BC, Nandakumar DN. A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis. Prostate Cancer Prostatic Dis. 2007; 10:356-59.10.1038/sj.pcan.450096517404581Search in Google Scholar

36. Yalcin O, Karatas F, Erulas FA, Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int. 2004; 93:863-6.10.1111/j.1464-410X.2003.04729.x15050006Open DOISearch in Google Scholar

37. Arikan S, Akcay T, Konukoglu D, Obek C, Kural AR. The relationship between antioxidant enzymes and bladder cancer. Neoplasma. 2005; 52:314-7.Search in Google Scholar

38. Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR, et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol. 2002; 156:1002-10.10.1093/aje/kwf14712446256Search in Google Scholar

39. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol. 2004; 21:392-401.10.1007/s00345-003-0382-8Search in Google Scholar

40. Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma L, et al. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett. 2008; 264:299-308.10.1016/j.canlet.2008.01.041Search in Google Scholar

41. Patumraj S, Yoisungneon P. Curcumin as a therapeutic agent against cancer. Asian Biomed. 2007; 1:239-52.Search in Google Scholar

42. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006; 7:766-74.10.1016/S1470-2045(06)70862-2Open DOISearch in Google Scholar

43. Kurtul N, Cil MY, Pacaci SD. Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maras powder). J Biomed Sci. 2005; 12:559-63.10.1007/s11373-005-4563-x15959629Open DOISearch in Google Scholar